Market revenue in 2023 | USD 1,206.3 million |
Market revenue in 2030 | USD 2,296.2 million |
Growth rate | 9.6% (CAGR from 2023 to 2030) |
Largest segment | Ceramics & bioactive glass biomaterials |
Fastest growing segment | Polymers Biomaterials |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ceramics & Bioactive Glass Biomaterials, Polymers Biomaterials, Calcium Phosphate Cements, Metal Biomaterials, Composites |
Key market players worldwide | Koninklijke DSM NV, Evonik Industries AG, Stryker Corp, DePuy Synthes, Zimmer Biomet Holdings Inc, Globus Medical Inc Class A, Exactech, Matexcel, AdvanSource Biomaterials Corporation, Invibio, CAM Bioceramics, Heraeus |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic biomaterials market will help companies and investors design strategic landscapes.
Ceramics & bioactive glass biomaterials was the largest segment with a revenue share of 31.99% in 2023. Horizon Databook has segmented the China orthopedic biomaterials market based on ceramics & bioactive glass biomaterials, polymers biomaterials, calcium phosphate cements, metal biomaterials, composites covering the revenue growth of each sub-segment from 2018 to 2030.
n. Key factors anticipated to drive the market in China are growing prevalence of musculoskeletal disorders among the working population and increasing geriatric population. MSDs are highly prevalent among the Chinese population, owing to which the country has one of the largest numbers of replacement and reconstruction surgeries performed each year.
China has also made substantial progress in the development of artificial joints and joint replacement surgeries. Furthermore, joint replacement is widely accepted as a successful treatment option in the country for many end-stage joint disorders, where non-operative solutions and medications have failed.
However, the orthopedics biomaterials market growth might get hindered in the long run. China medical coverage for reconstruction surgeries is low and moreover it is unaffordable for many citizens. This is a major challenge for the market growth in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the China orthopedic biomaterials market, including forecasts for subscribers. This country databook contains high-level insights into China orthopedic biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account